KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 130 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 1.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $11,053,000 | -66.4% | 3,140,071 | -4.6% | 0.26% | -62.1% |
| Q2 2015 | $32,851,000 | -21.5% | 3,291,711 | +0.1% | 0.70% | -25.7% |
| Q1 2015 | $41,841,000 | -9.0% | 3,286,844 | +1.2% | 0.94% | -14.4% |
| Q4 2014 | $45,959,000 | +2.4% | 3,247,990 | -0.5% | 1.10% | -6.3% |
| Q3 2014 | $44,874,000 | +40.2% | 3,263,528 | +56.8% | 1.17% | +53.7% |
| Q2 2014 | $32,012,000 | -9.1% | 2,081,792 | +0.7% | 0.76% | -14.0% |
| Q1 2014 | $35,223,000 | – | 2,067,053 | – | 0.88% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 1,312,006 | $16,990,000 | 16.50% |
| VHCP Management, LLC | 1,000,273 | $12,954,000 | 6.97% |
| Cormorant Asset Management, LP | 1,700,000 | $22,015,000 | 6.39% |
| HARVEY CAPITAL MANAGEMENT INC | 890,500 | $11,531,000 | 4.76% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 859,672 | $11,133,000 | 2.50% |
| Rhenman & Partners Asset Management AB | 400,000 | $5,180,000 | 2.03% |
| SECTORAL ASSET MANAGEMENT INC | 2,758,950 | $35,728,000 | 1.54% |
| NORTHPOINTE CAPITAL LLC | 1,289,711 | $16,701,000 | 1.47% |
| Knoll Capital Management, LLC | 200,000 | $2,592,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,483,260 | $19,208,000 | 1.00% |